About Bovie Medical (AMEX:BVX)
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through three segments: Core, OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor's offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers its products in electrosurgery, cauteries and other products categories.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment Wholesale
- Sub-Industry: N/A
- Symbol: AMEX:BVX
- CUSIP: N/A
- Web: www.boviemedical.com/
- Market Cap: $105.85 million
- Outstanding Shares: 30,859,000
- 50 Day Moving Avg: $2.97
- 200 Day Moving Avg: $2.58
- 52 Week Range: $1.87 - $5.75
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -85.75
- P/E Growth: -2.02
- Annual Revenue: $37.75 million
- Price / Sales: 2.80
- Book Value: $0.76 per share
- Price / Book: 4.51
- EBITDA: ($3,600,000.00)
- Net Margins: -13.35%
- Return on Equity: -21.74%
- Return on Assets: -15.98%
- Average Volume: 156,770 shs.
- Beta: -0.06
- Short Ratio: 2.61
Frequently Asked Questions for Bovie Medical (AMEX:BVX)
What is Bovie Medical's stock symbol?
Bovie Medical trades on the AMEX under the ticker symbol "BVX."
How were Bovie Medical's earnings last quarter?
Bovie Medical Co. (AMEX:BVX) released its earnings results on Wednesday, August, 2nd. The company reported ($0.04) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The business earned $9.80 million during the quarter, compared to analyst estimates of $8.60 million. Bovie Medical had a negative net margin of 13.35% and a negative return on equity of 21.74%. View Bovie Medical's Earnings History.
When will Bovie Medical make its next earnings announcement?
Where is Bovie Medical's stock going? Where will Bovie Medical's stock price be in 2017?
1 equities research analysts have issued twelve-month target prices for Bovie Medical's stock. Their forecasts range from $6.00 to $6.00. On average, they expect Bovie Medical's share price to reach $6.00 in the next twelve months. View Analyst Ratings for Bovie Medical.
Who are some of Bovie Medical's key competitors?
Some companies that are related to Bovie Medical include Chromadex Corp (CDXC), OncoCyte Corp (OCX), Kadmon Holdings (KDMN), Silence Therapeutics plc (SLN), Organovo Holdings (ONVO), Synthetic Biologics (SYN), Asterias Biotherapeutics (AST), Asterias Biotherapeutics (AST), Sinclair Pharma PLC (SPH), Palatin Technologies (PTN), ImmuPharma PLC (IMM), Verona Pharma Plc (VRP), aTyr Pharma (LIFE), MaxCyte (MXCT), Matinas BioPharma Holdings (MTNB), Summit Therapeutics PLC (SUMM), Arch Therapeutics (ARTH) and Ekf Diagnostics Holding PLC (EKF).
Who are Bovie Medical's key executives?
Bovie Medical's management team includes the folowing people:
- Andrew Makrides Esq., Executive Chairman of the Board
- John Robert Saron, President, Chief Sales and Marketing Officer, Director
- Robert L. Gershon, Chief Executive Officer, Director
- Charles Thomas Orsatti, Vice Chairman of the Board
- Jay D. Ewers, Chief Financial Officer, Treasurer, Secretary
- Moshe Citronowicz, Senior Vice President
- John J. McCarthy, Chief Commercialization Officer
- John C. Andres, Independent Director
- Scott R. Davidson, Independent Director
- Michael E. Geraghty, Independent Director
How do I buy Bovie Medical stock?
Shares of Bovie Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bovie Medical's stock price today?
MarketBeat Community Rating for Bovie Medical (AMEX BVX)MarketBeat's community ratings are surveys of what our community members think about Bovie Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Bovie Medical stock can currently be purchased for approximately $3.43.
Consensus Ratings for Bovie Medical (AMEX:BVX) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$6.00|Consensus Price Target History for Bovie Medical (AMEX:BVX)
Analysts' Ratings History for Bovie Medical (AMEX:BVX)
(Data available from 10/17/2015 forward)
|11/21/2016||Piper Jaffray Companies||Initiated Coverage||Overweight||$6.00|
|8/3/2016||JMP Securities||Reiterated Rating||Outperform||$5.00|
Earnings History for Bovie Medical (AMEX:BVX)Earnings History by Quarter for Bovie Medical (AMEX BVX)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/2/2017||Q2 2017||($0.03)||($0.04)||$8.60 million||$9.80 million||View||Listen|
|5/15/2017||Q1 2017||($0.05)||($0.06)||$8.39 million||View||N/A|
|3/9/2017||Q4 2016||($0.01)||($0.04)||$9.90 million||$9.49 million||View||Listen|
|10/26/2016||Q216||($0.03)||($0.01)||$9.25 million||$10.10 million||View||Listen|
|8/1/2016||Q2 2016||($0.06)||($0.02)||$8.55 million||$9.30 million||View||N/A|
|5/11/2016||Q116||($0.05)||($0.07)||$7.17 million||$7.80 million||View||Listen|
|3/17/2016||Q415||($0.06)||($0.05)||$8.69 million||$8.30 million||View||Listen|
|11/4/2015||Q315||($0.06)||($0.07)||$7.40 million||$7.80 million||View||N/A|
|8/6/2015||Q215||($0.09)||($0.06)||$7.27 million||$7.27 million||View||N/A|
|5/8/2015||Q1 2015||($0.13)||($0.14)||$6.92 million||$6.13 million||View||N/A|
|8/5/2014||Q2 2014||($0.02)||($0.03)||$6.95 million||View||N/A|
|5/15/2014||Q1 2014||($0.05)||($0.01)||$6.48 million||View||N/A|
|11/14/2013||Q3||($0.02)||$6.70 million||$5.80 million||View||N/A|
|8/14/2013||Q2 2013||($0.06)||$7.44 million||$6.04 million||View||N/A|
|5/15/2013||Q1 2013||($0.02)||$6.73 million||$5.70 million||View||N/A|
|4/1/2013||Q4 2012||($0.05)||$6.10 million||$6.83 million||View||N/A|
Earnings Estimates for Bovie Medical (AMEX:BVX)
Current Year EPS Consensus Estimate: $-0.11 EPS
Next Year EPS Consensus Estimate: $-0.04 EPS
Dividend History for Bovie Medical (AMEX:BVX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Bovie Medical (AMEX:BVX)Insider Trades by Quarter for Bovie Medical (AMEX:BVX)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/17/2016||John J Mccarthy III||Insider||Buy||90,750||$3.30||$299,475.00|| |
|12/22/2015||John J Mccarthy III||Insider||Buy||25,000||$1.98||$49,500.00|| |
|12/21/2015||Moshe Citronowicz||VP||Buy||20,000||$1.84||$36,800.00|| |
|12/21/2015||Robert Gershon||CEO||Buy||10,000||$1.82||$18,200.00|| |
|8/14/2015||Robert Gershon||CEO||Buy||20,000||$2.39||$47,800.00|| |
Headline Trends for Bovie Medical (AMEX:BVX)
Latest Headlines for Bovie Medical (AMEX:BVX)
|Bovie Medical Co. (BVX) Set to Announce Earnings on Tuesday|
www.americanbankingnews.com - October 17 at 5:20 AM
|Bovie Medical Co. (BVX) Upgraded to "Hold" at Zacks Investment Research|
www.americanbankingnews.com - October 16 at 8:44 PM
|ETFs with exposure to Bovie Medical Corp. : September 22, 2017|
finance.yahoo.com - September 22 at 3:49 PM
|Bovie Medical Corp. :BVX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017|
finance.yahoo.com - September 21 at 4:39 PM
|Bovie Medical Co. (AMEX:BVX) Issues Quarterly Earnings Results|
www.americanbankingnews.com - August 3 at 3:38 PM
|Bovie reports 2Q loss|
finance.yahoo.com - August 2 at 10:34 PM
|Bovie Medical Co. (AMEX:BVX) to Release Quarterly Earnings on Wednesday|
www.americanbankingnews.com - July 26 at 7:32 AM
|ETFs with exposure to Bovie Medical Corp. : July 10, 2017|
finance.yahoo.com - July 10 at 4:47 PM
|Bovie Medical Corporation to Release Second Quarter 2017 Financial Results on August 2, 2017|
finance.yahoo.com - July 10 at 4:47 PM
|Bovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece - Business Wire (press release)|
www.businesswire.com - March 29 at 12:33 PM
|Bovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece|
us.rd.yahoo.com - March 27 at 12:45 PM
|BOVIE MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events|
biz.yahoo.com - December 22 at 9:13 PM
|CVS Health Introduces Transform Diabetes Care Program|
us.rd.yahoo.com - December 16 at 4:24 PM
|BOVIE MEDICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia|
biz.yahoo.com - November 14 at 6:53 AM
|Bovie Medical Corporation (BVX) Subsides on Stock Offerings|
www.baystreet.ca - November 12 at 11:11 AM
|Bovie Medical Prices Public Offerings Of Common Stock|
www.thestreet.com - November 10 at 12:27 PM
|Bovie Medical Corporation's (BVX) CEO Rob Gershon on Q3 2016 Results - Earnings Call Transcript|
seekingalpha.com - October 27 at 8:32 AM
|Bovie Medical Receives FDA 510(k) Clearance For Its 'PlazXact™' Ablator|
www.thestreet.com - August 18 at 9:28 PM
|JMP Securities Reviews Bovie Medical's Q2 Results|
www.benzinga.com - August 2 at 9:40 PM
|Bovie Medical's (BVX) CEO Robert Gershon on Q2 2016 Results - Earnings Call Transcript|
seekingalpha.com - August 2 at 8:48 AM
|BOVIE MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi|
biz.yahoo.com - March 18 at 8:31 AM
|BOVIE MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits|
biz.yahoo.com - October 19 at 4:11 PM
Bovie Medical (BVX) Chart for Tuesday, October, 17, 2017